XPAR
CLARI
Market cap1.31bUSD
Oct 09, Last price
3.32EUR
1D
2.79%
1Q
-16.37%
Jan 2017
-88.07%
IPO
-90.70%
Name
Korian SE
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Clariane SE, established in Paris, France, in 2001 and known as Korian until its rebranding in June 2023, specializes in delivering comprehensive medical and non-medical care and support. The company serves senior citizens and individuals facing either temporary or chronic health challenges through a diverse range of provisions. These offerings encompass residential facilities like long-term nursing homes, specialized medical clinics, and senior living communities, including assisted living and co-housing arrangements. Furthermore, Clariane extends its services to include in-home care, various support programs, and hospitalization. Its operational footprint spans multiple European nations, including France, Germany, Italy, Spain, the Netherlands, Belgium, and the United Kingdom.
Related entities
Subsidiaries (19)
CLARIANE & PARTENAIRES IMMOBILIER 2
KINETIKA SARDEGNA S.R.L.
KORIAN BELGIUM
OPPCI CLARIANE IMMOBILIER
SANTA CROCE S.R.L.
SEGESTA S.P.A. S.B.
SILVER IMMOBILIARE S.R.L.
SL FINANCE
"IL CHIOSCO SRL"
ASSISI PROJECT SOCIETA' PER AZIONI
CLARIANE & PARTENAIRES IMMOBILIER 1
CLARIANE IMMOBILIER ALLEMAGNE 6
GERESS SOCIETA' A RESPONSABILITA' LIMITATA", IN FORMA ABBREVIATA "GERESS S.R.L."
ISAV S.P.A.
ITALIAN HOSPITAL GROUP SPA
KORIAN CONCESIONES 2022 SL
MSH S.R.L.
RSA BERZO INFERIORE S.R.L.
RSA BORNO SOCIETA' DI PROGETTO SPA
Key people
Gilberto Nieddu
Director - Employees Representative · since 2022
Ondrej Novak
Institutional Director · since 2024
Anne Ramon
Director - Representative of Holding Malakoff Humanis · since 2018
Independent Director · since 2021
Patricia Damerval
Independent Director · since 2024
Independent Director · since 2014
Philippe Leveque
Independent Director · since 2022
Independent Chairman of the Board · since 2025
Markus Mueschenich
Independent Director · since 2017
Headquarters & legal address
21 RUE BALZAC
21-25
PARIS 75008
FR
21-25
PARIS 75008
FR
Previous name
KORIAN
Valuation
Title in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT |